Carcinogenesis

You have full text access to this OnlineOpen article

The combination of epigallocatechin gallate and curcumin suppresses ERα-breast cancer cell growth in vitro and in vivo

  1. Tiffany J. Somers-Edgar,
  2. Marissa J. Scandlyn,
  3. Emma C. Stuart,
  4. Martin J. Le Nedelec,
  5. Sophie P. Valentine,
  6. Rhonda J. Rosengren†,*

Article first published online: 20 DEC 2007

DOI: 10.1002/ijc.23328

Issue

International Journal of Cancer

International Journal of Cancer

Volume 122, Issue 9, pages 1966–1971, 1 May 2008

Additional Information

How to Cite

Somers-Edgar, T. J., Scandlyn, M. J., Stuart, E. C., Le Nedelec, M. J., Valentine, S. P. and Rosengren, R. J. (2008), The combination of epigallocatechin gallate and curcumin suppresses ERα-breast cancer cell growth in vitro and in vivo. Int. J. Cancer, 122: 1966–1971. doi: 10.1002/ijc.23328

Author Information

  1. Department of Pharmacology and Toxicology, University of Otago, Dunedin, New Zealand

  1. †

    Fax: +64-3-479-9140.

*Department of Pharmacology and Toxicology, 18 Frederick Street, Adams Building, University of Otago, Dunedin, New Zealand

Publication History

  1. Issue published online: 25 FEB 2008
  2. Article first published online: 20 DEC 2007
  3. Manuscript Accepted: 5 NOV 2007
  4. Manuscript Received: 16 AUG 2007

Funded by

  • University of Otago research
  • University of Otago Postgraduate Scholarships

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (227K)

References

  • 1
    Arts ICW,van de Putte B,Hollman PC. Catechin contents of food commonly consumed in The Netherlands. I. Fruits, vegetables, staple foods and processed foods. J Agr Food Chem 2000; 48: 1746–51.
  • 2
    Lin J-K,Lin-Shiau S-Y. Mechanisms of cancer chemoprevention by curcumin. Proc Natl Sci Counc Repub China 2001; 25: 59–66.
  • 3
    Goldbohm RA,Hertog MG,Brants HA,van Poppel G,van den Brandt PA. Consumption of black tea and cancer risk: a prospective cohort study. J Natl Cancer Inst 1996; 88: 93–100.
  • 4
    Zheng W,Doyle TJ,Kushi LH,Sellers TA,Hong CP,Folsom AR. Tea consumption and cancer incidence in a prospective cohort study of postmenopausal women. Am J Epidemiol 1996; 144: 175–82.
  • 5
    Ji BT,Chow WH,Hsing AW,McLaughlin JK,Dai Q,Gao YT,Blot WJ,Fraumeni JF,Jr. Green tea consumption and the risk of pancreatic and colorectal cancers. Int J Cancer 1997; 70: 255–8.
    Direct Link:
  • 6
    Imai K,Suga K,Nakachi K. Cancer-preventive effects of drinking green tea among a Japanese population. Prev Med 1997; 26: 769–75.
  • 7
    Nakachi K,Suemasu K,Suga K,Takeo T,Imai K,Higashi Y. Influence of drinking tea on breast cancer malignancy among Japanese patients. Jap J Cancer Res 1998; 89: 254–61.
  • 8
    Thangapazham RL,Singh AK,Sharma A,Warren J,Gaddipati JP,Maheshwari RK. Green tea polyhphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo. Cancer Lett 2007; 245: 232–41.
  • 9
    Chen ZP,Schell JB,Ho CT,Chen KY. Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts. Cancer Lett 1998; 129: 173–9.
  • 10
    Chisholm K,Bray BJ,Rosengren RJ. Tamoxifen and epigallocatechin gallate (EGCG) are synergistically cytotoxic to MDA-MB-231 human breast cancer cells. Anticancer Drugs 2004; 15: 889–97.
  • 11
    Shao ZM,Shen ZZ,Liu CH,Sartippour MR,Go VL,Heber D,Nguyen M. Curcumin exerts multiple suppressive effects on human breast carcinoma cells. Int J Cancer 2002; 98: 234–40.
    Direct Link:
  • 12
    Verma SP,Goldin BR,Lin PS. The inhibition of the estrogenic effects of pesticides and environmental chemicals by curcumin and isoflavonoids. Environ Health Perspect 1998; 106: 807–12.
  • 13
    Ahmad N,Feyes DK,Nieminen AL,Agarwal R,Mukhtar H. Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J Natl Cancer Inst 1997; 89: 1881–6.
  • 14
    Gupta S,Ahmad N,Nieminen A,Mukhtar H. Growth inhibition, cell cycle dysregulation, and induction of apoptosis by green tea constituent (−)-epigallocatechin-3-gallate in androgen-sensitive and androgen-sensitive human prostate carcinoma cells. Toxicol Appl Pharmacol 2000; 164: 82–90.
  • 15
    Huh SW,Bae SM,Kim YW,Lee JM,Namkoong SE,Lee IP,Kim SH,Kim CK,Ahn WS. Anticancer effects of (−)-epigallocatechin-3-gallate on ovarian carcinoma cell lines. Gynecol Oncol 2004; 94: 760–8.
  • 16
    Roy AM,Baliga MS,Katiyar SK. Epigallocatechin-3-gallate induces apoptosis in estrogen receptor-negative human breast carcinoma cells via modulation in protein expression of p53 and Bax and caspase-3 activation. Mol Cancer Ther 2005; 4: 81–90.
  • 17
    Chen H,Zhang ZS,Zhang YL,Zhou DY. Curcumin inhibits cell proliferation by interfering with the cell cycle and inducing apoptosis in colon carcinoma cells. Anticancer Res 1999; 19: 3675–80.
  • 18
    Squires MS,Hudson EA,Howells L,Sale S,Houghton CE,Jones JL,Fox LH,Dickens M,Prigent SA,Manson MM. Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells. Biochem Pharmacol 2003; 65: 361–76.
  • 19
    Ramachandran C,You W. Differential sensitivity of human mammary epithelial and breast carcinoma cell lines to curcumin. Breast Cancer Res Treat 1999; 54: 269–78.
  • 20
    Mukhopadhyay A,Bueso-Ramos C,Chatterjee D,Pantazis P,Aggarwal BB. Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines. Oncogene 2001; 20: 7597–609.
  • 21
    Singh S,Aggarwal BB. Activation of transcription factor NF-kB is suppressed by curcumin (diferuloul-methane). J Biol Chem 1995; 270: 24995–5000.
  • 22
    Mukhopadhyay A,Banerjee S,Stafford LJ,Xia C,Liu M,Aggarwal BB. Curumin-induced suppresssion of cell prolieration correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation. Oncogene 2002; 21: 8852–61.
  • 23
    Kumar A,Dhawan S,Hardegen NJ,Aggarwal BB. Curcumin (diferuloylmethane) inhbition of tumor necrosis factor (TNF)-mediated adhesion of monocytes to endothelial cells by suppression of cell surface expression of adhesion molecules and of nuclear factor-kB activation. Biochem Pharmacol 1998; 55: 775–83.
  • 24
    Aggarwal S,Ichikawa H,Takada Y,Sandur SK,Shishodia S,Aggarwal BB. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptottic and metastatic gene products through suppression of IkBa kinase and AKt activation. Mol Pharmacol 2006; 669: 195–206.
  • 25
    Aggarwal BB,Banerjee S,Bharadwaj U,Sung B,Shishodia S,Sethi G. Curcumin induces the degradation of cyclin E expression through ubiquitin-dependent pathway and up-regulates cyclin-dependent kinase inhibitors p21 and p27 in multiple human tumor cell lines. Biochem Pharm 2007; 73: 1024–32.
  • 26
    Huang MT,Lou YR,Xie JG,Ma W,Lu YP,Yen P,Zhu BT,Newmark H,Ho CT. Effect of dietary curcumin and dibenzoylmethane on formation of 7,12-dimethylbenz[a]anthracene-induced mammary tumors and lymphomas/leukemias in Sencar mice. Carcinogenesis 1998; 19: 1697–700.
  • 27
    Inano H,Onoda M. Prevention of radiation-induced mammary tumors. Int J Radiat Oncol Biol Phys 2002; 52: 212–23.
  • 28
    Inano H,Onoda M,Inafuku N,Kubota M,Kamada Y,Osawa T,Kobayashi H,Wakabayashi K. Chemoprevention by curcumin during the promotion stage of tumorigenesis of mammary gland in rats irradiated with γ-rays. Carcinogenesis 1999; 20: 1011–18.
  • 29
    Dorai T,Cao YC,Dorai B,Buttyan R,Katz AE. Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo. Prostate 2001; 47: 293–303.
    Direct Link:
  • 30
    Pereira MA,Grubbs CJ,Barnes LH,Li H,Olson GR,Eto I,Juliana M,Whitaker LM,Kelloff GJ,Steele VE,Lubet RA. Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz[a]anthracene-induced mammary cancer in rats. Carcinogenesis 1996; 17: 1305–11.
  • 31
    Singletary K,MacDonald C,Wallig M,Fisher C. Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced mammary tumorigenesis and DMBA-DNA adduct formation by curcumin. Cancer Lett 1996; 103: 137–41.
  • 32
    Tanaka H,Hirose M,Kawabe M,Sano M,Takesada Y,Hagiwara A,Shirai T. Post-initiation inhibitory effects of green tea catechins on 7,12-dimethylbenz[a]anthracene-induced mammary gland carcinogenesis in female Sprague-Dawley rats. Cancer Lett 1997; 116: 47–52.
  • 33
    Bhide SV,Azuine MA,Lahiri M,Telang NT. Chemoprevention of mammary tumor virus-induced and chemical carcinogen-induced rodent mammary tumors by natural plant products. Breast Cancer Res Treat 1994; 30: 233–42.
  • 34
    Kavanagh KT,Hafer LJ,Kim DW,Mann KK,Sherr DH,Rogers AE,Sonenshein GE. Green tea extracts decrease carcinogen-induced mammary tumor burden in rats and rate of breast cancer cell proliferation in culture. J Cell Biochem 2001; 82: 387–98.
    Direct Link:
  • 35
    Liao S,Umekita Y,Guo J,Kokontis JM,Hiipakka RA. Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate. Cancer Lett 1995; 96: 239–43.
  • 36
    Sartippour MR,Heber D,Ma J,Lu Q,Go VL,Nguyen M. Green tea and its catechins inhibit breast cancer xenografts. Nutr Cancer 2001; 40: 149–56.
  • 37
    Roos W,Fabbro D,Kung W,Costa SD,Eppenberger U. Correlation between hormone dependency and the regulation of epidermal growth factor receptor by tumour promoters in human mammary carcinoma cells. Proc Natl Acad Sci USA 1986; 83: 991–5.
  • 38
    Biswas DK,Shi Q,Baily S,Strickland I,Ghosh S,Perdee AB,Iglehart JD. NF-kB activation in human breast cancer specimens and its role in cell proliferation and apoptosis. Proc Natl Acad Sci USA 2004; 101: 10137–42.
  • 39
    Masuda M,Suzui M,Lim JT,Deguchi A,Soh JW,Weinstein IB. Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction. J Exp Ther Oncol 2002; 2: 350–9.
    Direct Link:
  • 40
    Stuart EC,Larsen L,Rosengren RJ. Potential mechanisms for the synergistic cytotoxicity elicited by 4-hydroxytamoxifen and epigallocatechin gallate in MDA-MB-231cells. Int J Oncol 2007; 30: 1407–12.
  • 41
    Sartippour MR,Pietras R,Marquez-Garban DC,Chen H-W,Heber D,Henning SM,Sartippour G,Zhange L,Lu M,Weinberg O,Rao JY,Brooks MN. The combination fo green tea and tamoxifen is effective against breast cancer. Carcinogenesis 2006; 27: 2424–33.
  • 42
    Kunnumakkara AB,Guha S,Krishnan S,Diagaradjane P,Gelovani J,Aggarwal BB. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, antiogenesis and inhibition of nuclear factor-kB-regulated gene products. Cancer Res 2007; 67: 3853–61.
  • 43
    Khafif A,Schantz SP,Chou T-C,Edelstein D,Sacks PG. Quantitation of chemopreventive synergism between (−)-epigallocatechin-3-gallate and curcumin in normal, premalignant and malignant human oral epithelial cells. Carcinogenesis 1998; 19: 419–24.
  • 44
    Eckert RL,Crish JF,Efimova T,Balasubramanian S. Antioxidants regulate normal keratinocyte differentiation. Biochem Pharmacol 2004; 68: 1125–31.
  • 45
    Balasubramanian S,Eckert RL. Green tea polyphenol and curcumin inversely regulate human involucrin romoter activity via opposing effects on CCAAT/enahncer-binding protein function. J Biol Chem 2004; 23: 24007–14.
  • 46
    Landis-Piwowar KR,Huo C,Chen D,Milacic V,Shi G,Chan TH,Dou QP. A novel prodrug of the green tea poplyphenol (−)-epigallocatechin-3-gallate as a potential anticancer agent. Cancer Res 2007; 67: 4303–10.
  • 47
    Skehan P,Storeng R,Scudiero D,Monks A,McMahon J,Vistica D,Warren JT,Mokesch H,Kenney S,Boyd MR. New colorimetric cytotoxicity assay for anti-cancer drug screening. J Natl Cancer Inst 1990; 82: 1107–12.
  • 48
    Zamzami N,Marchetti P,Castedo M,Zanin C,Vayssiere J-L,Petit PX,Kroemer G. Reduction in mitochondrial potential constitutes an early irreversible step of programmed important death in vivo. J Exp Med 1995; 181: 1661–72.
  • 49
    Piper JT,Singhal SS,Salameh MS,Torman RT,Awasthi YC,Awasthi S. Mechanisms of anticarcinogenic properties of curcumin: the effect of curcumin on glutathione linked detoxification enzymes in rat liver. Int J Biochem Cell Biol 1998; 30: 445–56.
  • 50
    Sharma RA,Iresone CR,Verschoyle RD,Hill KA,Williams ML,Leuratti C,Manson MM,Marnett LJ,Steward WP,Gescher A. Effects of dietary curcumin on glutathione S-transferase and malondialdehyde-DNA adducts in rat liver and colon mucosa: relationship with drug levels. Clin Cancer Res 2001; 7: 1452–8.
  • 51
    Valentine S,Le Nedelec MJ,Menzies AR,Scandlyn MJ,Goodin MG,Rosengren RJ. Curcumin modulates drug metabolizing enzymes in the female Swiss Webster mouse. Life Sci 2006; 78: 2391–8.
  • 52
    Goodin MG,Bray BJ,Rosengren RJ. Sex- and strain-dependent effects of epigallocatechin gallate (EGCG) and epigallocatechin (ECG) in the mouse. Food Chem Toxicol 2006; 44: 1496–504.
  • 53
    Goodin MG,Rosengren RJ. Epigallocatechin gallate modulates CYP450 isoforms in the female Swiss Webster mouse. Toxicol Sci 2003; 76: 262–70.
  • 54
    Banerjee S,Zhang Y,Ali S,Bhuiyan M,Wang Z,Chiao PJ,Philip PA,Abbruzzese S,Fazlul H. Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer. Cancer Res 2005; 65: 9064–72.
  • 55
    Shao Z-M,Shen Z-Z,Liu C-H,Sartippour MR,Go VL,Heber D,Nguyen M. Curcumin exerts multiple suppressive effects on human breast carcinoma cells. Int J Cancer 2002; 98: 234–40.
    Direct Link:
  • 56
    Cheng AL,Hsu CH,Lin J-K,Hsu MM,Ho YF,Shen TS,Ko JY,Lin JT,Lin BR,Ming-Shiang W,Yu HS,Jee SH, et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 2001; 21: 2895–900.
  • 57
    Suh H-W,Kang S,Kwon K-S. Curcumin attenuates glutamate-induced HT22 cell death by suppressing MAP kinase signaling. Mol Cell Biochem 2007; 298: 187–94.
  • 58
    Lin YG,Kunnumakkara AB,Nair A,Merritt WM,Han LY,Armaiz-Pena GN,Kamat AA,Spannuth WA,Gershenson DM,Lutgendorf SK,Aggarwal BB,Sood AK. Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kB pathway. Clin Cancer Res 2007; 13: 3423–30.
  • 59
    Shoba G,Joy D,Joseph T,Majeed M. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 1998; 64: 353–6.
View Full Article (HTML) Get PDF (227K)